Casana and Massachusetts General Hospital (MGH) Cardiovascular Disease Prevention Center (CVDPC) have successfully conducted a collaborative research study titled “Validation of a novel toilet seat-based cuffless blood pressure measurement technology and association with left ventricular mass index” using the Heart Seat.
The study aimed to establish the correlation between seat-derived blood pressure (BP) and cuff-derived BPs obtained during routine clinical visits for cardiac rehabilitation (CR). Additionally, the researchers examined the association between seat-derived BP and left ventricular (LV) mass.
Each subject enrolled underwent a minimum of three and a maximum of four study visits, during which their blood pressure was measured using the following methods:
- Blood pressure cuff
- Heart Seat while sitting on the device
The study has now concluded, providing insights into the effectiveness of the Heart Seat as a reliable and non-intrusive method for measuring blood pressure.
Recommended insights
Heart Health Intelligence Raises Funds for a Revolutionary In-Home Cardiovascular Monitoring Device
Company Closes its $2.2M Seed Round to Support Commercialization of The Heart Seat™
Hypotension vs. Hypertension | Why Low Blood Pressure is Also Important to Monitor
What is Hypotension? Hypotension, not to be confused with https://casanacare.com/blog-an..., describes low blood pressure which can result in the brain not receiving enough blood. While low blood pressure is often perceived as a positive alternative to...Read More
Boldly Growing: A Start-Up Founder’s Guide to Sustainable Success
Austin led the company through its acquisition by Vista Equity Partners in 2017, and subsequent $4B+ IPO in 2020. Austin is a Forbes 30 Under 30, was named Ernst & Young Technology Entrepreneur of the Year in 2016, and earned recognition as one of the nation's top 50 philanthropists in 2017.